新聞/Radius Health, Menarini Group Says Phase 3 Trial of Breast Cancer…Radius Health, Menarini Group Says Phase 3 Trial of Breast Cancer Drug Candidate Elacestrant Meets Primary Endpoint2022年5月20日09:05 [UTC]